UBS analyst Adam Berlin has increased the price target for Omnicom to $124 from $120, while maintaining a Buy rating on the shares.
This adjustment comes after Omnicom's strong Q3 results, although the firm expects that investors may be disappointed by guidance indicating a slowdown in Q4.
The guidance is seen as slightly cautious, with expectations for Q4 organic growth exceeding 5%, subject to the successful execution of project-based work.
UBS also predicts that Omnicom will provide guidance for 2025 organic growth that surpasses current consensus estimates.